Jecho Laboratories, Inc. is a clinical-stage drug discovery company developing innovative biologics, including antibodies, fusion proteins, cytokines, T cell engagers, and ADCs. Our primary therapeutic area of focus is oncology, including solid tumors. We recently published several of our preclinical programs at AACR 2025, SITC 2025, and World ADC Congress. Jecho has also developed extensive VHH and scFv fully human phage libraries for discovery and our internal pipelines. Jecho has 2 US FDA IND clearances and 10 cumulative IND clearances.

Jecho is located in Frederick, MD and is supported by research and manufacturing sites in China.